Quantcast

Latest Bone density Stories

2009-07-28 04:00:00

CLEVELAND, July 28 /PRNewswire/ -- More than 340,000(2) women suffer from postmenopausal osteoporosis (PMO) in Ohio and more than 900,000(3) are at risk for the disease. According to a census report on the prevalence of osteoporosis, the number of women suffering from the disease is predicted to increase in Ohio by more than 22 percent by 2020. Despite this predicted increase, a national Harris Interactive survey commissioned by the Know My Bones Council showed (n=889 with PMO; n=912...

2009-06-25 07:24:45

Regular bone mineral density monitoring in postmenopausal women may be unnecessary and potentially misleading. Researchers looked at how the effects of the drug alendronate (a widely used osteoporosis drug) differ between individuals. They found after three years therapy, almost all (97.5%) women treated with alendronate showed at least a modest increase in hip bone mineral density. In addition, this treatment effect did not vary substantially between individuals. Researchers say this makes...

2009-06-24 07:58:29

Monitoring bone mineral density in postmenopausal women taking osteoporosis drugs (bisphosphonates) is unnecessary and potentially misleading, concludes a study published on bmj.com today.Osteoporosis is a major public health problem, particularly in older women because bone density falls after the menopause as oestrogen levels dwindle. Low bone mineral density is an important risk factor for fractures.Some guidelines recommend regular monitoring of bone mineral density in postmenopausal...

2009-06-02 08:05:00

Up to 50 percent of RA patients show evidence of focal erosions, and RA doubles the risk of osteoporosis and fracturesRheumatoid arthritis (RA), the most common form of inflammatory arthritis, affects almost three percent of people over age 65. RA patients experience pain, functional limitations and two forms of disabling bone disease: focal erosions and osteoporosis. After five years of disease, up to 50 percent of RA patients show evidence of focal erosions and RA doubles the risk of...

2009-06-01 00:15:00

- Single infusion of Reclast increases bone mass for two years in postmenopausal women with osteopenia, a condition that can lead to osteoporosis(1) - Approximately 22 million women in US have osteopenia, or low bone mass, putting them at increased risk of fractures of hip, spine and wrist(2,3) - Reclast already approved as once-yearly infusion for treatment of postmenopausal osteoporosis(1) EAST HANOVER, N.J., June 1 /PRNewswire/ -- Reclast(R) (zoledronic acid) Injection has been approved...

2009-05-22 09:54:13

Hyperkyphosis, or "dowager's hump" "” the exaggerated forward curvature of the upper spine seen commonly in elderly women "” may predict earlier death in women whether or not they have vertebral osteoporosis, UCLA researchers have found.In a study published in the May 19 issue of Annals of Internal Medicine, researchers found that older white women with both vertebral fractures and the increased spinal curvature that results in the bent-over posture characteristic of hyperkyphosis...

2009-05-14 05:00:00

Survey Respondents' Lives Significantly Impacted After Breaking a Bone Special Council of Health and Women's Groups Formed to Encourage Women to Make Bone Health a Priority Before They Break a Bone WASHINGTON, May 14 /PRNewswire/ --- The Know My Bones Council today announced results from a national Harris Interactive survey, which found that one-out-of-five women with postmenopausal osteoporosis (PMO) are retiring later than anticipated and nearly half (48 percent) blame the current...

2009-05-13 12:13:00

CINCINNATI, May 13, 2009 /PRNewswire/ -- Today, the United States Court of Appeals for the Federal Circuit ruled in favor of The Procter & Gamble Company (P&G) in the patent infringement lawsuit filed by P&G against Teva Pharmaceuticals USA, Inc. The positive ruling protects P&G's rights in the U.S. to exclusively market the osteoporosis therapy Actonel(R) (risedronate sodium) tablets. Actonel is commercialized through a collaboration between Procter & Gamble...

2009-05-11 10:33:00

Non-adherent women up to six times more likely to experience a fracture WOONSOCKET, R.I., May 11 /PRNewswire/ -- Data released today by CVS Caremark (NYSE: CVS) indicates that 87 percent of women 18 years and older with osteoporosis, who were taking a drug therapy to treat the disease, did not experience a fracture during the two-year study period. The CVS Caremark data also found that those women with osteoporosis between the ages of 18-64 who were not on therapy were 5.7 times more likely...

2009-05-07 11:41:05

Postmenopausal women with hot flashes and night sweats had lower lumbar and total hip bone mineral density, U.S. researchers found. The study, published in the journal Menopause, found postmenopausal women with vasomotor symptoms -- which include hot flashes and night sweats -- had lower bone mineral density. Researchers at the University of California, Los Angeles, and colleagues analyzed data for 2,213 women between the ages of 42-52 who participated in the bone sub-study of the Study...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.